Abstract
PorcineTaenia solium cysticercosis, recognized as a model of the human disease, was used to analyze the effect of the anthelminthic drug praziquantel on hosts and parasites. The drug (50 mg/kg daily) was given over 15 days in the feed of 13 cysticercotic and 9 control pigs. Changes in the number, size and appearance of brain parasites were seen by computerized tomography immediately after the last dose of praziquantel, although not all cysticerci had disappeared by day 47 following the end of the treatment. Muscle parasites became small and hyperdense shortly after treatment and disappeared from tomographic images afterwards. No alterations were found in EEGs or in brain-stem auditory and somatosensory evoked potentials. Muscle cysticerci showed increasing degrees of degeneration with time after treatment, and an augmented inflammatory reaction was concomitantly observed. In contrast, more heterogeneous results were obtained in parasites lodged in the brain, since viable cysts and less intense inflammatory reactions were found in the brain at different times after treatment. Physiological evaluation of the parasites showed that evagination was inhibited immediately after treatment and that oxygen consumption decreased with time. The results of this investigation suggest that praziquantel damages cysticerci and that the inflammatory reaction destroys and eliminates them.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aluja AS, Vargas G (1988) The histopathology of porcine cysticercosis. Vet Parasitol 25:65–77
Barker CF, Billinghman RE (1977) Immunologically privileged sites. Adv Immunol 25:1–54
Chotas HG, Bourne JR, Teschan PE (1979) Heuristic techniques in the quantification of the electroencephalogram in renal failure. Comput Biomed Res 12:299–312
Correa D, Laclette JP, Rodriguez-Del-Rosal E, Merchant MT, Flisser A (1987) Heterogeneity ofTaenia solium cysticerci obtained from different naturally infected pigs. J Parasitol 73:443–445
De Ghetaldi LD, Norman RM, Douille AW Jr (1983) Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. Ann Intern Med 99:179–181
De Rezende GL, Paz G (1986) Praziquantel: datos farmacodinámicos, toxicológicos y farmacocinéticos. Rev Univ Ind Santander 14:77–90
Dixon HBF, Lipscomb FM (1961) Cysticercosis: an analysis and follow up of 450 cases. Privy Council Med Res Spec Rep Ser 299:1–58
Earnest MP, Reller LB, Filley CM, Grek AJ (1987) Neurocysticercosis in the United States: 35 cases and a review. Rev Infect Dis 9:961–978
Flisser A (1988) Neurocysticercosis in Mexico. Parasitol Today 4:131–137
González D, Rodriguez-Carbajal J, Aluja AS, Flisser A (1987) Cerebral cysticercosis in pigs studied by computed tomography and necropsy. Vet Parasitol 26:55–71
Groll E (1984) Praziquantel. Adv Pharmacol Chemother 20:219–238
Hernandez-Jauregui PA, Márquez-Monter H, Sastré-Ortiz S (1973) Cysticercosis of the central nervous system in hogs. Am J Vet Res 34:451–453
Leblanc R, Knowles KF, Melanson D, LacLean JD, Rouleau G, Farmer JP (1986) Neurocysticercosis: surgical and medical management with praziquantel. Neurosurgery 18:419–427
Mahajan RC (1982) Geographical distribution of human cysticercosis. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F (eds) Cysticercosis, present state of knowledge and perspectives. Academic, New York, pp 39–46
Medawar PB (1948) Immunity to homologous grafted skin; fate of skin homografts transplanted to brain, to subcutaneous tissue and to anterior chamber of the eye. Br J Exp Pathol 29:58–69
Minguetti G, Ferreira M (1983) Computed tomography in neurocysticercosis. J Neurol Neurosurg Psychiatry 46:936–942
Overbosch D, Nes JCM van der, Groll E, Diekmann HW, Polderman AM, Mattie H (1987) Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. Eur J Clin Pharmacol 33:287–292
Rodriguez-Carbajal J, Boleaga-Durán B (1982) Neuroradiology of human cysticercosis. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F (eds) Cysticercosis, present state of knowledge and perspectives. Academic, New York, pp 179–200
Schenone H (1973) Algunas consideraciones sobre la cisticercosis porcina en América Latina. Bol Chil Parasitol 28:106–107
Schenone H, Villaroel F, Rojas A, Ramirez R (1982) Epidemiology of human cysticercosis in Latin America. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F (eds) Cysticercosis present state of knowledge and perspectives. Academic, New York, pp 25–38
Sotelo J, Torres B, Rubio-Donnadieu F, Escobedo F, Rodriguez-Carbajal J (1985) Praziquantel in the treatment of neurocysticercosis: long-term follow-up. Neurology 35:752–754
Spina-Franca A, Machado LR, Nobrega JPS, Livramento JA, Diekmann HW, Groll E, De Rezende GL (1985) Praziquantel in the cerebrospinal fluid in neurocysticercosis. Arq Neuro-Psiquiatr 3:234–259
Velasco-Suarez M, Bravo-Becherelle MA, Quirasco F (1982) Human cysticercosis: medical, social implications and economic impact. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F (eds) Cysticercosis, present state of knowledge and perspections. Academic, New York, pp 47–52
Zenteno-Alanis G (1982) A classification of human cysticercosis. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F (eds) Cysticercosis, present state of knowledge and perspectives. Academic, New York, pp 107–126
Zhi-biao X, Wen-kai Ch, Hui-lan Z, Man-ling F, Wei-ji C (1985) Praziquantel in treatment of cysticercosis cellulosae. Report of 200 cases. Clin Med J 98:489–494
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flisser, A., Gonzalez, D., Shkurovich, M. et al. Praziquantel treatment of porcine brain and muscleTaenia solium cysticercosis. Parasitol Res 76, 263–269 (1990). https://doi.org/10.1007/BF00930823
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00930823